It has been appreciated for quite some time that the two leaflets of a eukaryotic plasma membrane have distinct lipid compositions (Devaux [@CR23]; Gordesky and Marinetti [@CR38]). Now there is much evidence for additional layers of structural complexity in the plasma membrane. For example, fluorescently tagged annexins with different lipid specificities will label distinct regions of the plasma membrane in smooth muscle cells (Draeger et al. [@CR26]). Such distinct subdomains in the plasma membrane are also reminiscent of much more specialized structures, like the rhodopsin-rich photosensory discs in the vertebrate retina. Similarly, the plasma membrane of the yeast *Saccharomyces cerevisiae* contains at least two microscopically distinct subdomains (Malinska et al. [@CR74], [@CR75]). One of these compartments contains the plasma membrane ATPase Pma1, whereas the other contains a number of permeases, including Can1 and Fur4 (Bagnat et al. [@CR6]; Dupré and Haguenauer-Tsapis [@CR27]; Hearn et al. [@CR44]; Malinska et al. [@CR74], [@CR75]). By contrast, the amino acid permease Gap1 is found in both compartments of the yeast plasma membrane (Lauwers and Andre [@CR64]; Lauwers et al. [@CR65]).

It has been proposed that these subdomains of the plasma membrane can be equated with structures variously termed lipid rafts or detergent-resistant membranes (DRMs), which have been proposed in a variety of eukaryotic systems (Bagnat et al. [@CR6]; Simons and Toomre [@CR101]). This proposal remains quite controversial (Kenworthy [@CR54]; Munro [@CR76]). In particular, it is unclear whether there is any relationship between plasma membrane microdomains observed in vivo by fluorescence microscopy and DRM fractions obtained in vitro (Lichtenberg et al. [@CR69]). By definition, a DRM fraction can only be observed after extraction of the membrane with detergent and thus may not correspond to structures in the native membrane (Lichtenberg et al. [@CR69]). Based on studies of model membranes, it has been argued that DRM fractions might be artifactually created by detergent treatment (Heerklotz [@CR45]; Heerklotz et al. [@CR46]; Keller et al. [@CR53]; Lichtenberg et al. [@CR69]), particularly in the presence of sterols or sphingolipids. Attempts to perturb detergent-resistant subdomains in vivo via depletion of sterols are similarly subject to alternative interpretations (Kenworthy [@CR54]).

Despite the questionable correspondence between in vivo observations of lateral segregation or microdomain formation and in vitro examination of DRM components, it is clear that the formation, turnover, and biological significance of membrane microdomains are important topics of current research. Establishment of these unique regions, whether highly specialized or rudimentary, requires lateral segregation of both lipid and protein components within the plane of the plasma membrane (Bogdanov et al. [@CR12]). *S. cerevisiae* has proven to be a valuable system for studying this phenomenon, due largely to thorough elucidation of lipid biosynthetic pathways in this organism (Carman and Henry [@CR14]), particularly for sphingolipids (Daum et al. [@CR19]; Dickson [@CR24]).

Advances have been made in our understanding of the underlying biophysical basis of the lateral segregation found in plasma membranes. Sphingolipids and sterols seem important both for "raft" assembly in vivo and for formation of the DRM fraction in vitro (Bagnat et al. [@CR6]; Dupré and Haguenauer-Tsapis [@CR27]; Hearn et al. [@CR44]). There is also evidence that certain glycerophospholipids are important in establishment of discrete plasma membrane subdomains, including phosphatidylethanolamine (PE) (Opekarova et al. [@CR81]) and a specialized phosphatidyinositol with a very long fatty acid substituent that is a component of GPI-anchored proteins (Fujita et al. [@CR34]). It has been reported that localization of certain permeases to one of the plasma membrane subdomains in *S. cerevisiae* depends on maintenance of the transmembrane electrochemical potential, whereas other segregated plasma membrane proteins, including the eisosome component Sur7 (Walther et al. [@CR110]) and the plasma membrane ATPase Pma1, are not affected by membrane depolarization (Grossmann et al. [@CR40]). Pma1 is able to form high molecular weight oligomers in the presence of ceramide (Bagnat et al. [@CR7]; Lee et al. [@CR66]), suggesting that, at least in some cases, protein-protein interactions can contribute to lateral segregation.

In eukaryotic cells, aminophospholipids, like PE, are normally markedly enriched in the inner leaflet of the plasma membrane. Some of the enzymes that contribute to the maintenance of such plasma membrane asymmetry have been elucidated in yeast. For PE and phosphatidylcholine (PC), there are both inward-directed and outward-directed lipid translocases (Kean et al. [@CR52]; Pomorski et al. [@CR84]). Thus, establishment of the observed asymmetric distribution demands balance between these opposing catalytic activities. The inward-directed PE translocases in the plasma membrane of *S. cerevisiae* are proposed to be Dnf1 and Dnf2, two members of a novel subgroup (class 4) of membrane transporters of the P-type ATPase family (Hua et al. [@CR47]; Pomorski et al. [@CR84]), although there is some ambiguity as to whether these proteins are responsible for translocation of phosphatidylserine (Chen et al. [@CR16]; Stevens et al. [@CR102]). For their proper localization and function, Dnf1 and Dnf2 associate with a noncatalytic subunit, Lem3/Ros3 (Kato et al. [@CR50]; Saito et al. [@CR91]). Dnf1 and Dnf2 also catalyze inward translocation of other compounds, including PC, lysophospholipids, and ether-linked lipid antifungals (Elvington et al. [@CR30]; Hanson et al. [@CR43]; Riekhof et al. [@CR87]). Dnf1, Dnf2, and Lem3 all have paralogues that reside in intracellular membranes and that have been implicated in endocytosis, intracellular vesicular trafficking, and polarized growth (Chen et al. [@CR16]; Furuta et al. [@CR35]; Hua et al. [@CR47]; Pomorski et al. [@CR84]; Saito et al. [@CR92]). Interestingly, in some instances, these biological processes do not seem to require the translocase function of these proteins per se (Natarajan et al. [@CR78]; Noji et al. [@CR79]).

The outward-directed PE translocases in the plasma membrane of *S. cerevisiae* are thought to be members of a different superfamily of membrane transporters, the ATP-binding-cassette (ABC) transporters (Pomorski et al. [@CR84]). The *S. cerevisiae* plasma membrane likely contains as many as 10 ABC transporters; of these, Pdr5 and Yor1 have been specifically implicated as outward-directed PE translocases (Pomorski et al. [@CR84]). Both had been identified previously via their ability to mediate resistance to a broad spectrum of antimicrobial drugs (Balzi et al. [@CR8]; Bissinger and Kuchler [@CR11]; Cui et al. [@CR18]; Decottignies et al. [@CR22]; Katzmann et al. [@CR51]; Kralli et al. [@CR59]). The *S. cerevisiae* genome encodes two other ABC transporters that are closely related to Pdr5, which have been designated Pdr10 (67% identity to Pdr5) and Pdr15 (75% identity to Pdr5). Our work has shown that Pdr15 has considerable functional overlap with Pdr5 and can also mediate drug export (Schüller et al. [@CR95]; Wolfger et al. [@CR112]). Unexpectedly, a *pdr5∆ pdr15∆* double mutant strain exhibited *increased* outer-leaflet PE (Schüller et al. [@CR95]), indicating that loss of the activity of two putative outward-directed translocases was somehow offset, presumably by decreased activity of the inward-directed translocases. Our findings suggest, therefore, that maintenance of plasma membrane PE asymmetry is under some type of feedback control, reminiscent of the interplay observed between glycerophospholipid asymmetry and sphingolipid transport (Kihara and Igarashi [@CR55]).

Pdr10 has been presumed to play a role in pleiotropic drug resistance only by virtue of its resemblance to Pdr5 and Pdr15 (Abolmaali et al. [@CR1]; Decottignies et al. [@CR22]) and to have a function that overlaps with those of Pdr5 and Pdr15 only because expression of the *PDR10* gene involves the same transcription factors (Pdr1 and Pdr3) that control *PDR5* and *PDR15* expression (Wolfger et al. [@CR111]). By contrast, for example, the ABC transporter Pdr12 (39% identity to Pdr5) is under the control of a dedicated transcription factor (War1) and has a well-defined and unique function, namely, export of weak organic acids such as sorbate (Kren et al. [@CR60]; Piper et al. [@CR83]; Schüller et al. [@CR94]). In any event, the properties, subcellular localization, and function of Pdr10 had not heretofore been directly examined experimentally.

Here we describe our analysis of the physiological role of Pdr10. First, we constructed a functional Pdr10-GFP chimera to visualize its distribution in vivo. Second, we also examined the behavior of Pdr10 upon biochemical fractionation of cell extracts. Third, we constructed a null mutation and compared the phenotypic characteristics of *pdr10∆* cells to those of otherwise isogenic *PDR10*^*+*^ cells. Fourth, we analyzed various properties of the cell envelope (plasma membrane and cell wall) and performed additional genetic analysis to pinpoint the underlying molecular causes of the defects and phenotypes observed. Our findings demonstrate that Pdr10 contributes in a significant way to maintaining proper lateral segregation of Pdr12 by helping to exclude it from the DRM fraction. To our knowledge, the function of Pdr10 in establishment of the normal plasma membrane microenvironment for another protein is a novel role for an ABC transporter in cell biology.

Materials and Methods {#Sec1}
=====================

Strains, Plasmids, and Growth Conditions {#Sec2}
----------------------------------------

Yeast strains used in this study are listed in Table [1](#Tab1){ref-type="table"}. The strains generated in the course of this study were constructed either by standard yeast genetic methods (Sherman et al. [@CR97]) or by one-step gene replacement via integration of appropriate products of the polymerase chain reaction (PCR) using short flanking homology (Wach et al. [@CR108]). Standard rich media (YPD) and defined dropout media (SCD) were used for yeast cultivation (Sherman et al. [@CR97]). *Escherichia coli* strain DH5α (Hanahan [@CR42]) was used for routine construction and propagation of plasmids, and *Pfu* Turbo polymerase (Stratagene, La Jolla, CA) and *Taq* Gold polymerase (Roche) were used for PCR.Table 1*S. cerevisiae* strains used in this studyStrainGenotypeSource/referenceW303-1A*MAT****a****ura3-1 leu2-3,112 his3-11,15 trp1-1 ade2-1 can1-100*Sherman et al. ([@CR97])W303-1B*MATα ura3-1 leu2-3,112 his3-11,15 trp1-1 ade2-1 can1-100*Sherman et al. ([@CR97])BYB67*MAT****a****/MATα ura3-1/ura3-1 leu2-3,112/leu2-3, 112 his3-11,15/his3-11,15 trp1-1/trp1-1 ADE2/ade2-1 LYS2/lys2::hisG can1-100/can1-100*Shulewitz et al. ([@CR98])WKK7W303-1A *ste6∆::HIS3*Kuchler et al. ([@CR62])NRY201W303-1A *pdr5∆::HIS3MX6*Schüller et al. ([@CR95])NRY212W303-1A *pdr15∆::TRP1*Schüller et al. ([@CR95])NRY230^a^W303-1A *pdr5∆::URA3MX4 pdr10∆::HIS3MX6*This studyNRY236^a^W303-1A *pdr10∆::HIS3MX6 pdr15∆::TRP1*This studyNRY243^b^W303-1A *pdr10∆::HIS3MX6*This studyNRY251^b^W303-1A *pdr10∆::URA3MX4*This studyNRY301^b^W303-1A *pdr12∆::HIS3MX6*This studyNRY334^b^W303-1A *YOL075c∆::URA3MX4*This studyNRY336^b^W303-1A *pdr18∆::HIS3MX6*This studyNRY366^a^NRY251 *pdr12∆::HIS3MX6*This studyNRY407^b^W303-1B *cho1∆::HIS3MX6*This studyNRY427^a^W303-1A *dnf1∆::URA3MX4 dnf2∆::kanMX4*This studyNRY409^b^W303-1A *sur1∆::URA3MX4*This studyNRY410^b^W303-1A *ipt1∆::URA3MX4*This studyNRY526^a^NRY243 *sur1∆::URA3MX4*This studyNRY534^a^NRY243 *ipt1∆::URA3MX4*This studyNRY549^b^W303-1A *lem3∆::URA3MX4*This studyNRY551^a^W303-1A *pdr10∆::HIS3MX6 lem3∆::URA3MX4*This studyNRY558^a^W303-1A *pdr10∆::HIS3MX6 dnf1∆::URA3MX4 dnf2∆::kanMX4*This studyNRY601^b^NRY243 *chs3∆::URA3MX4*This studyNRY602^b^W303-1A *chs3∆::URA3MX4*This studyNRY608^b^W303-1A *chs6∆::URA3MX4*This studyNRY610^b^NRY243 *chs6∆::URA3MX4*This studyNRY802^c^W303-1A *ADE2 lys2::hisG*This studyNRY804^c^W303-1B *ADE2 lys2::hisG*This studyNRY904^d^W303-1A *LEM3-mh::kanMX6*This studyNRY906^d^NRY804 *PDR5-GFP::HIS3MX6*This studyNRY908^d^W303-1A *pdr10∆::HIS3MX6 LEM3-mh::kanMX6*This studyNRY912^d^NRY802 *PDR10-GFP::HIS3MX6*This studyNRY914^d^NRY802 *LEM3-GFP::HIS3MX6*This studyNRY915^d^NRY804 *PDR12-GFP::kanMX6*This studyNRY916^d^NRY802 *pdr10∆::URA3MX4 PDR5-GFP::HIS3MX6*This studyNRY918^d^NRY802 *pdr10∆::URA3MX4 LEM3-GFP::HIS3MX6*This studyNRY921^d^NRY802 *DNF1-GFP::HIS3MX6*This studyNRY923^d^NRY802 *DNF2-GFP::HIS3MX6*This studyNRY925^d^NRY802 *pdr10∆::HIS3MX6 PDR12-GFP::kanMX6*This studyNRY929^d^NRY802 *pdr10∆::URA3MX4 DNF2-GFP::HIS3MX6*This studyNRY930^d^W303-1A *PDR10-mh::kanMX6*This studyNRY932^d^NRY802 *pdr10∆::URA3MX4 DNF1-GFP::HIS3MX6 LYS2*This studyYPH499*MAT****a****ade2-101*^*oc*^*his3-∆200 leu2-∆1 lys2-801a trp1-∆63 ura3-52*Sikorski and Hieter ([@CR100])YHW10 NYPH499 *pdr10∆::URA3*This study^a^Constructed by sporulation and tetrad dissection of appropriate diploid parents^b^Constructed by integration of PCR products amplified with appropriate primers using pFA6aHIS3MX6 or pAG60 as template and verified by PCR on genomic DNA^c^Constructed by tetrad dissection of BYB67^d^Constructed by integration of PCR products amplified with appropriate primers using pFA6a-GFP(S65T)-HIS3MX6, pFA6a-GFP(S65T)-kanMX6, or pNR99A as template and verified by PCR on genomic DNA

Plasmids pFAkanMX4, pFA6aHIS3MX6, pAG60, pFA6aGFP(S65T)kanMX6, and pFA6aGFP(S65T)HIS3MX6 have been described previously (Goldstein et al. [@CR37]; Wach et al. [@CR108], [@CR109]). To construct pNR99A, which permits PCR-based C-terminal tagging of yeast proteins with a tandem c-Myc-His~6~ tag followed by a STOP codon and transcriptional terminator (the "mh" tag), plasmid yGALSte6(∆A-box)-myc-his (gift from E. E. Swartzman, Thorner Lab), which encodes a functional Ste6 with a C-terminal mh tag, was amplified by PCR with appropriate primers to permit cloning of a fragment containing 165 bp from the 3′ end of *STE6* followed by the mh tag coding sequence and a STOP codon, which was inserted into pFA6aGFP(S65T)kanMX6 using unique *Bam*HI and *Asc*I sites. The presence of a single, correctly cloned insert was verified by restriction digestion and nucleotide sequencing. This plasmid permits integration of the mh tag with or without linker sequence derived from the C-terminus of Ste6. In the present work, the Lem3-mh fusion lacks any linker, whereas the Pdr10-mh chimera incorporates a pentapeptide (--SNQSS--) sequence derived from the *STE6* gene that is situated between the C-terminal residue of Pdr10 and the mh tag. Both Pdr10-mh and Lem3-mh were functional, as judged by a phenotypic test (normal Calcofluor sensitivity compared to untagged strains and *pdr10∆* or *lem3∆* strains).

Immunoblotting {#Sec3}
--------------

Rabbit polyclonal antisera used in this study were anti-Ste2 (David et al. [@CR20]), anti-Chs2 and anti-Chs3 (R. Schekman, University of California, Berkeley, USA), anti-Drs2 (T. Graham, Vanderbilt University, Nashville, TN, USA), anti-Pdr12 (Piper et al. [@CR83]), anti-Pdr5 (Egner et al. [@CR28]), anti-Snq2 (Mahé et al. [@CR73]), anti-Ycf1 and anti-Yor1 (S. Moye-Rowley, University of Iowa, Iowa City, USA), ant-Gas1 (A. Conzelmann, University of Fribourg, Fribourg, Switzerland), and anti-Hxt1 (E. Boles, Goethe-Universität Frankfurt, Frankfurt-am-Main, Germany). Mouse monoclonal antibodies used in this study were anti-Fks1 mAb (Y. Ohya, University of Tokyo, Toyko, Japan), anti-Pma1 mAb (F. Portillo, Universidad Autonoma de Madrid, Madrid, Spain), anti-Vph1 mAb (T. Stevens, University of Oregon, Eugene, OR, USA), anti-ALP/Pho8 mAb (Molecular Probes), and mAb 9E10 directed against the c-Myc epitope used in this work (Evan et al. [@CR32]).

Two techniques were used to quantitate immunoblots. For samples analyzed by chemiluminescence, exposures were taken using Kodak type MS film, which was scanned and quantitated using densitometry and open-source image analysis software (NIH Image, NIH, Bethesda, MD, USA). Alternately, blots were probed with infrared dye-labeled secondary antibodies and scanned using an infrared scanner (Odyssey; Li-Cor, Inc., Lincoln, NE, USA). Results obtained by these two techniques were crosschecked using samples of equivalent protein content from the total membrane fraction of wild-type cells and *pdr10∆* mutants, which were blotted with anti-Pdr12 antiserum. When determined by either method, the value obtained for the ratio of Pdr12 content in *pdr10∆* mutants to that in wild-type cells was essentially the same. Thus, measurements of relative protein content made using either procedure were comparable.

Growth Assays {#Sec4}
-------------

All spot-dilution assays were performed using overnight cultures grown in YPD. Aliquots from such cultures were adjusted to an A~600~ ~nm~ = 1 with sterile H~2~O. Three 10-fold serial dilutions were made in sterile H~2~O, and aliquots (5 μl) of all four cell suspensions were spotted onto YPD plates lacking or containing the additive to be tested. After the liquid in each spot was absorbed, the plates were inverted, incubated at 30°C for 2 days, and then photographed. The following additives were tested at the indicated concentrations: Calcofluor White (Fluorescent Brightener 28; Sigma Chemical Co., St. Louis, MO, USA), 0 to 8 μg/ml; Congo Red, 100 μg/ml; ketoconazole, 2 μM; rhodamine 6G, 20 μM; and cycloheximide, 100 ng/ml. For assay of sorbate sensitivity, the cell suspensions were spotted onto YPD plates that were buffered using 50 mM sodium succinate (pH 3.5) and contained various concentrations of potassium sorbate (0 to 4 mM), and the resulting plates were photographed after incubation at 30°C for 3 days.

Detergent sensitivity was assessed using a diffusion ("halo") assay. Cells of the strain to be tested (0.1 A~600~ ~nm~ unit) from overnight cultures grown in YPD were diluted into 3 ml of YPD top agar and spread on the surface of a YPD plate. Sterile filter disks (1-cm diameter; Whatman 3MM) were placed on the seeded cell lawn and samples (10 μl) of solutions (10%, w/v) of the detergents to be tested were spotted onto the disks. Plates were then incubated right-side-up at 30°C for 2 days.

Microscopy {#Sec5}
----------

A functional GFP-tagged chitin synthase (Chs3-GFP) was expressed from plasmid pCRP12 with simultaneous overexpression of Chs7 from pRS315-CHS7, as previously described (Valdivia et al. [@CR107]). Exponentially growing cultures of strains W303-1A and NRY251 carrying these plasmids were treated with α-factor mating pheromone to induce cell cycle arrest and shmoo formation, and then pheromone was washed out with fresh, prewarmed medium to permit synchronized re-entry into the cell cycle. The cellular distribution of Chs3-GFP was visualized under a fluorescence microscope (Olympus BH-2) equipped with a 100× objective and appropriate bandpass filters (Chroma Technology). Digital images were captured using an Olympus charge-coupled device (CCD) camera and Magnafire-SP software (Optronics). To visualize the distribution of fluorescently labeled chitin in the cell wall, cells were stained with Calcofluor White following a published procedure (Pringle [@CR86]). Briefly, exponentially growing cells were collected by centrifugation, washed twice in H~2~O, incubated in aqueous Calcofluor White (0.1 mg/ml) for 5 min at room temperature, washed three times with H~2~O, recollected by centrifugation, resuspended at an appropriate dilution in H~2~O, and viewed using appropriate filters under the same fluorescence microscope described above. The intensity of Calcofluor staining in photomicrographs was quantitated using NIH Image; pilot experiments examining chitin levels in wild-type, *pdr10∆,* and *cho1∆* cells by fluorescence-activated cell sorting were in agreement with quantitation of photomicrographs.

To examine uptake of the water-soluble fluorescent dye Lucifer Yellow as a measure of fluid phase endocytosis, cells (0.5 A~600~ ~nm~ unit) from exponentially growing cultures of W303-1A and NRY243 grown in YPD were collected by centrifugation and resuspended in fresh YPD medium (90 μl). An aliquot (10 μl) of an aqueous stock solution (40 mg/ml) of Lucifer Yellow CH (Molecular Probes, Inc., Eugene, OR, USA) was added and the cell suspension was incubated with gentle agitation at 30°C for 1 h. After this incubation, the cells were recollected, washed with 1 ml H~2~O, and viewed using appropriate filters under the Olympus fluorescence microscope. Similarly, for uptake of the lipophilic fluorescent dye FM 4-64, this compound (16 μM final concentration) was added from a concentrated stock (16 mM) in DMSO directly to cultures of exponentially growing W303-1A and NRY243 cells and the suspension was incubated with gentle agitation at 30°C for 40 min, then washed with H~2~O and viewed using appropriate filters under the Olympus fluorescence microscope. To examine filipin staining and sterol polarization, log phase cells were resuspended in SCD medium buffered to pH 3.5 with 25 mM sodium succinate. Aliquots were treated with α-factor as described above or with solvent control. After pheromone treatment, cells were washed twice in SCD buffered with 1× lysis buffer (defined below) and stained with 10 μg/ml filipin for 5 min in the dark at room temperature. Cells were then washed with SCD buffered with lysis buffer and examined on the Olympus fluorescence microscope. To visualize actin, 134 μl of 37% formaldehyde (commercial) was added to1-ml log phase cultures of appropriate strains and the mixture incubated for 30 min at room temperature with gentle agitation. Cells were washed twice in phosphate-buffered saline supplemented with 1 mg/ml bovine serum albumin and then resuspended in 50 μl of the same buffer. Ten microliters of rhodamine-phalloidin from a stock of 300 units dissolved in methanol was added, and cells were incubated for 30 min in the dark at 4°C with gentle agitation. Cells were then washed three times with the same buffer, resuspended in 10 μl buffer supplemented with 20 μl Citifluor, and visualized by fluroescence microscopy.

The Pdr10-GFP, Pdr12-GFP, Pdr5-GFP, Lem3-GFP, Dnf1-GFP, and Dnf2-GFP chimeras were constructed by generating in-frame fusions of the coding sequence for GFP to the coding sequence of each protein at its resident locus in its respective chromosome using a PCR-based insertion method and plasmids containing the cognate genes as the template DNA (Wach et al. [@CR109]). The primers used for each construction were designed to retain the native C-terminal sequence of each protein, followed by a nonapeptide linker (--AAGRRIPGL--) and then by GFP. Proper integration was verified by PCR. Retention of biological function of each chimera was assessed by its ability to complement the phenotype of the corresponding mutant: for Pdr5-GFP, restoration of resistance to rhodamine 6G; for Pdr12-GFP, restoration of resistance to sorbate; and for Pdr10-GFP, Lem3-GFP, Dnf1-GFP, and Dnf2-GFP, restoration of resistance to Calcofluor White.

To visualize the subcellular localization of each chimera (except Pdr10-GFP), cells from exponentially growing cultures were washed once in 10 mM Tris--HCl (pH 7.0) and then viewed using a Nikon TE300 fluorescence microscope equipped with a 100× objective and appropriate bandpass filters (Chroma Technology). Digital images were captured with a bottom-ported Orca 100 CCD camera (Hamamatsu, Bridgewater, NJ, USA) and Phase 3 imaging software (Northern Exposure, Glen Mills, PA, USA). To examine Pdr10-GFP, we determined empirically that the most reliable results were obtained for stationary phase cells (i.e., cultures grown in YPD for\~2 days), which were then, as for the others, washed once in 10 mM Tris--HCl (pH 7.0) prior to viewing under the fluorescence microscope. For time-lapse photomicroscopy, cells were immobilized by spotting onto polylysine-coated coverslips to minimize their movement and short exposure times (at high gain) were taken to capture as many frames as possible to minimize the loss of signal intensity due to photobleaching. When cells were treated with the actin filament-depolymerizing drug latrunculin A, an aliquot (2 μl) containing this compound was added from a concentrated stock (10 mM) in DMSO to a sample (150 μl) of cells from a culture of strain NRY912 that had grown in YPD for 2 days. After incubation with end-over-end mixing for 10 min at 30°C, the cells were collected by centrifugation, washed in 10 mM Tris--HCl (pH 7.0), and examined using the Nikon fluorescence microscope.

Uptake of fluorescent C~6~-7-nitrobenz-2-oxa-1,3-diazol-4-yl-PE (NBD-PE) and C~6~-NBD-ceramide (NBD-Cer) (Avanti Polar Lipids) was monitored in exponentially growing cells from cultures grown in synthetic complete (SC) medium containing glucose (dextrose) as the carbon source (SCD), as follows. Cells were collected by centrifugation and resuspended 10-fold concentrated in 300 μl of prewarmed SCD, and then latrunculin A (4 μl) was added from a concentrated stock (10 mM) stock in DMSO. After incubation by end-over-end mixing for 5--10 min at 30°C, a sample (2 μl) of either NBD-PE or NBD-Cer, each from a concentrated stock (10 mM) in DMSO, was added while the suspension was subjected to vigorous vortex mixing (Grant et al. [@CR39]; Pomorski et al. [@CR84]). After a further incubation with end-over-end mixing for 30 min at 30°C, the cells were recollected and washed three times with ice-cold SC medium containing 2% sorbitol and 20 mM NaN~3~ (abbreviated SCNaN~3~) prior to viewing under the Nikon fluorescence microscope adjusted for optimal viewing of fluorescence emission in the same range as for fluorescein.

Preparation of Total Yeast Membranes {#Sec6}
------------------------------------

For membrane preparations, cells were inoculated into fresh, prewarmed YPD medium and grown at 30°C for one to three doublings. The cells were then chilled on ice at the same time that NaN~3~ and NaF were added (each at a 20 mM final concentration). After 10 min on ice, cells were harvested by centrifugation, washed with 10 ml ice-cold aqueous 20 mM NaN~3~--20 mM NaF, and resuspended in aliquots (0.12--0.15 g wet weight) that were flash-frozen in liquid N~2~ and stored at --80°C until used. For lysis, frozen cell pellets were resuspended in 650 μl ice-cold lysis buffer (50 mM Tris--HCl \[pH 7.4\], 150 mM NaCl, 5 mM EDTA) containing a protease inhibitor mix (Complete; Roche), 1 mM PMSF, 200 μM pepstatin A, and 5 μM MG-132 and then ruptured by five 1-min pulses of vigorous vortex mixing with glass or silica/zirconium beads (Biospec, Bartlesville, OK, USA) separated by 1 min of cooling on ice between each pulse. The resulting lysate was removed and then combined with the solutions generated by extracting the beads three times with 1-ml portions of ice-cold lysis buffer. The combined crude extract was subjected to centrifugation at 500 *g* for 5 min at 4°C to remove any broken beads, unlysed cells, cell walls, and other large debris. The clarified extract was subjected to centrifugation at 43,000 rpm for 1 h at 4°C in the TLA 100.3 rotor of a TL100 tabletop ultracentrifuge (Beckman). The resulting total membrane pellets were resuspended in 100 mM Tris--HCl (pH 7) containing 5% SDS, 40 μM pepstatin A, and 1 mM PMSF and warmed briefly to 37°C. The concentration of protein in these membrane preparations was determined using the bicinchoninic acid (BCA) method (Pierce Chemical Co.). Samples (typically 50 μg) were adjusted to 1× SDS-PAGE (sample buffer final concentration) by addition of an appropriate volume of 6×-concentrated SDS-PAGE sample buffer (Laemmli [@CR63]) and then divided into aliquots, which were frozen in liquid N~2~ and stored at --80°C before use. For analysis, an aliquot was thawed for 5 min at 37°C and then subjected to SDS-PAGE and immunoblotting.

Density Gradient Analysis of Detergent-Resistant Membranes {#Sec7}
----------------------------------------------------------

Analysis of DRMs was carried out using modifications of the Optiprep flotation procedure first developed by Simons and co-workers (Bagnat et al. [@CR6]). Total membrane pellets, prepared as described in the preceding section, were resuspended in 230 μl ice-cold buffer lysis buffer containing 1% Triton X-100 in a 4°C room and kept on ice for 1 h. A sample (170 μl) of this material was then added to LOAD solution (2500 μl Optiprep, 150 μl 10× lysis buffer, 150 μl 10% Triton X-100, containing PMSF, pepstatin A, and MG-132 at the same concentration as in lysis buffer), and the resulting mixture was transferred to ultracentrifuge tubes. The material in the tubes was then overlaid with 45% Optiprep (3 ml), 40% Optiprep (3 ml), 30% Optiprep (2.5 ml), and 0% Optiprep (200 μl); each of these solutions was in 0.5× lysis buffer, 0.5% Triton X-100, plus PMSF, pepstatin A, and MG-132. The resulting step gradient was subjected to centrifugation at 4°C for 18 h at 39,000 rpm in an SW41 rotor (Beckman). After centrifugation, fractions (600 μl) were collected, starting from the top of the gradient, and the material in each was precipitated by the addition of 1.2 ml 15% trichloroacetic acid (TCA) followed by immediate vortex mixing and incubation on ice for 45 min (Dupré and Haguenauer-Tsapis [@CR27]). The resulting precipitates were collected by centrifugation at maximum speed in a microfuge for 15 min, washed twice with \~250 μl ice-cold acetone, and solubilized by resuspension in 100 μl 5% SDS containing 0.1 M Tris base and brief incubation at 37°C. For ease of analysis, adjacent fractions were pooled so as to divide each gradient into nine separate portions. Aliquots of each of the nine portions were flash-frozen in liquid N~2~, some of which were used for protein determination and the remainder of which were used for analysis by SDS-PAGE and immunoblotting as described in the preceding section.

Lipid Analysis and TNBS Labeling {#Sec8}
--------------------------------

Cells were grown in 1 ml YPD supplemented with 50--250 μCi ^32^P-PO~4~^3--^ (10 mCi/ml; Perkin-Elmer) for 15--18 h to label phospholipids to a constant specific activity (Chang et al. [@CR15]). For reaction of intact yeast cells with 2,4,6-trinitrobenzene sulfonate (TNBS), a published procedure (Siegmund et al. [@CR99]) was used with only minor modifications. After radioactive labeling, cells were washed twice (1 ml each) in ice-cold TNBS buffer (120 mM NaHCO~3~ \[pH 8.4\], 40 mM NaCl), resuspended in 1 ml of the same buffer, and then aqueous TNBS (31 μl) was added from a concentrated stock (5%; Sigma). After incubation on ice with brief vortex mixing every 20 min over the course of 1 h, the cells were collected by brief centrifugation, washed three times (1 ml each) in ice-cold TNBS buffer, and resuspended in 600 μl CHCl~3~/CH~3~OH/0.1 N HCl (1:2:0.8) containing carrier lipid (Chang et al. [@CR15]). To promote lipid extraction after addition of the organic solvent mix, the cells were subjected to vigorous vortexing with glass beads for 3 min, and an additional 200 μl each of CHCl~3~ and 0.1 N HCl--0.5 M NaCl was added. To achieve good separation of the organic phase from the aqueous phase, the resulting mixture was subjected to centrifugation for 2 min at maximum speed in a microfuge. After withdrawing the organic phase, the lipids present in it were analyzed by two-dimensional thin-layer chromatography (2D-TLC) using CHCl~3~:MeOH:glacial acetic acid, 65:25:10 (dimension I), and CHCl~3~:MeOH:88% formic acid, 65:25:10 (dimension II) (Esko and Raetz [@CR31]), with nonradioactive trinitrophenyl-PE (TNP-PE) added as an internal standard. The radioactivity present in each spot on the resulting thin-layer chromatograms was quantitated by using the plates to expose phosphor storage screens, which were then analyzed using PhosphorImager or Typhoon imaging systems and ImageQuant software (Molecular Dynamics). The fraction of PE accessible to TNBS was calculated as TNP-PE/total PE (where total PE = TNP-PE + unreacted PE). TNP derivatives of phosphatidylserine (PS) were not observed. Comparing across independent experiments, this assay procedure yielded somewhat variable backgrounds, presumably due to slight differences in the fraction of inviable cells in cultures. We have established that there is no statistically significant difference in cell viability in strains cultured together, both by measurement of the ratio of colony-forming units to optical density and by methylene blue staining (Siegmund et al. [@CR99]) of TNBS-labeled, nonradioactive control cultures (\>500 cells counted per strain). Therefore, other strains should be measured accurately relative to the background TNBS labeling of wild-type cultures. All such measurements were performed with wild-type controls grown side by side. In every such trial, more PE was accessible in *pdr10∆* cells than in the control cultures (*n* = 7). In reporting the results, we have shown the actual labeled percentages in Fig. [6](#Fig6){ref-type="fig"}b for comparison to results of other workers, who have reported such data in this fashion (Pomorski et al. [@CR84]), and we have also reported the data as -fold differences in Table [2](#Tab2){ref-type="table"} (which should be more accurate, in light of the variable background).Table 2Total phospholipid composition of yeast strainsStrain^a^% Total phospholipid (as incorporated ^32^P label)TNBS labeling^b^PSPEPCPISPLWild type7.6 ± 0.620.2 ± 1.535.5 ± 2.124.1 ± 0.67.3 ± 0.91.0*pdr10∆*7.7 ± 0.520.3 ± 1.234.9 ± 1.123.9 ± 1.17.3 ± 1.3**2.5** **±** **0.6***dnf1∆ dnf2∆*7.5 ± 0.520.5 ± 0.536.3 ± 0.722.9 ± 0.57.8 ± 0.6**2.0** **±** **0.6***pdr10∆ dnf1∆ dnf2∆*7.7 ± 0.520.0 ± 0.535.9 ± 0.523.8 ± 0.57.4 ± 0.5**2.3** **±** **1.0***lem3∆*7.9 ± 0.120.7 ± 0.735.1 ± 1.523.6 ± 1.27.3 ± 0.4**2.7** **±** **0.5***pdr10∆ lem3∆*7.8 ± 0.220.3 ± 1.135.0 ± 0.524.1 ± 1.97.2 ± 0.4**2.7** **±** **1.0***pdr5∆*9.2 ± 0.522.7 ± 0.532.5 ± 0.519.8 ± 0.87.4 ± 0.50.9 ± 0.2*pdr5∆ pdr10∆*7.9 ± 1.020.3 ± 2.038.7 ± 1.718.7 ± 0.76.4 ± 1.3**0.3** **±** **0.2***pdr12∆*7.5 ± 0.519.7 ± 0.536.0 ± 0.524.0 ± 0.57.7 ± 0.81.6 ± 0.6*pdr10∆ pdr12∆*8.1 ± 0.519.9 ± 0.535.0 ± 1.124.0 ± 0.57.6 ± 0.51.5 ± 0.6*sur1∆*8.2 ± 0.519.1 ± 0.534.2 ± 0.623.3 ± 0.5**10.0** **±** **0.5**1.1 ± 0.2*pdr10∆ sur1∆*8.2 ± 0.519.7 ± 0.535.6 ± 0.722.5 ± 1.2**9.2** **±** **0.6**1.1 ± 0.2*cho1∆***\<0.111.0** **±** **3.052.7** **±** **6.2**26.9 ± 2.85.6 ± 1.2**2.7** **±** **0.8***Note*:*PS* phosphatidylserine;*PE* phosphatidylethanolamine;*PC* phosphatidylcholine;*PI* phosphatidylinositol;*SPL* total phosphosphingolipids. Lipids were labeled and analyzed as described under [Materials and Methods](#Sec1){ref-type="sec"}. Significant changes relative to wild type are in boldface^a^Strains were W303-1A (wild type), NRY243 (*pdr10∆*), NRY427 (*dnf1∆ dnf2∆*), NRY558 (*pdr10∆ dnf1∆ dnf2∆*), NRY549 (*lem3∆*), NRY551 (*pdr10∆ lem3∆*), NRY201 (*pdr5∆*), NRY230 (*pdr5∆ pdr10∆*), NRY301 (*pdr12∆*), NRY366 (*pdr10∆ pdr12∆*), NRY409 (*sur1∆*), and NRY526 (*pdr10∆ sur1∆*)^b^TNBS labeling is reported relative to the wild type

To analyze the composition of mature sphingolipids, cells were grown and labeled as described above, and sphingolipids were extracted using a previously published procedure with minor modifications (Dickson et al. [@CR25]). To samples (1 ml) of cultures incubated on ice was added 53 μl of 100% TCA. After 15 min, the acid-treated cells were washed twice with water (1 ml each), resuspended in 400 μl solvent E (diethyl ether/95% ethanol/water/pyridine, 5:15:15:1), and incubated at 60°C for 60 min with occasional vortex mixing. To separate the phases, the mixtures were subjected to centrifugation at maximum speed in a microfuge for 2 min and the sphingolipids present in the resulting organic phase were separated by ascending TLC with CHCl~3~:CH~3~OH:4.2 N NH~4~OH (9:7:2), which yields an acceptable resolution of the major sphingolipid species (Hama et al. [@CR41]), which were quantified as described in the preceding paragraph.

Nonradioactive TNP-PE was synthesized according to a published procedure (Gordesky and Marinetti [@CR38]) with minor modifications (Schüller et al. [@CR95]). PE (25 mg) was dissolved in 2.5 ml CHCl~3~ and added to a solution composed of 2.5 ml CH~3~OH, 1 ml CHCl~3~, 250 μl 5% aqueous NaHCO~3~, and 390 μl 5% aqueous TNBS. This resulting reaction mixture was incubated at room temperature for 2 h under argon gas and then mixed with 2 ml CHCl~3~ and 20 ml aqueous saturated NaCl (brine). After separating the phases, the organic phase was withdrawn, acidified with aqueous 1 N HCl, and re-extracted with 5 ml brine, and the resulting organic phase was dried over Na~2~SO~4~ and stored at --20°C under argon.

Results {#Sec9}
=======

Pdr10 is a Plasma Membrane Protein {#Sec10}
----------------------------------

To confirm that the product of the *PDR10* gene is a protein that is expressed at a detectable level and, if so, to establish its subcellular localization, a strain was constructed in which the green fluorescent protein (GFP) was fused in-frame to the C-terminal end of the open reading frame encoded by the chromosomal *PDR10* locus. We found that Pdr10-GFP localized to discrete, punctate structures in the plasma membrane (Fig. [1](#Fig1){ref-type="fig"}a). This chimera was most easily visualized in cells that had entered stationary phase (after 2 days of growth); however, the same pattern was observed in exponentially growing cells, only with a much weaker signal (data not shown). This finding is in agreement with global microarray analysis showing that transcription of *PDR10* is induced when cells undergo the diauxic shift from fermentative to nonfermentative growth as glucose becomes limiting (Roberts and Hudson [@CR88]) or when cells are treated with rapamycin, which mimics conditions of nutrient limitation (Huang et al. [@CR48]). Collectively, these findings suggest that the demand for this ABC transporter is greatest when cells are undergoing the stress of maintaining viability as growth rate slows down. Moreover, because our Pdr10-GFP construct was expressed from the endogenous *PDR10* promoter, transcription factors other than (or in addition to) Pdr1 and Pdr3 likely mediate *PDR10* expression under the stress of nutrient depletion.Fig. 1** **Pdr10 localizes to punctate structures in the plasma membrane and to the detergent-resistant fraction. **a** Strain NRY912 was grown in YPD for 2 days, and Pdr10-GFP was examined by fluorescence microscopy. Pdr10-GFP function was confirmed by Calcofluor sensitivity. **b** Strain NRY912 was grown for 2 days as in (**a**) but was treated with latrunculin A prior to microscopy. Bar for (**a**) and (**b**), 6 μm. **c** Cells were repeatedly exposed to look for movement of Pdr10-GFP puncta (*arrowheads*). Shorter exposure times and higher gain were used to permit the maximum number of exposures prior to loss of signal due to photobleaching. Bar, 3 μm. **d** Total membranes were isolated from log phase cells of strain NRY930, extracted with cold Triton X-100, and analyzed by flotation though Optiprep density gradients with subsequent immunoblotting as described under [Materials and Methods](#Sec1){ref-type="sec"}. Strain NRY930 expresses a *PDR10* allele with a C-terminal tandem *myc-*His~6~ (mh) tag. The function of the resulting Pdr10-mh protein was confirmed by Calcofluor sensitivity. Hxt1, Gas1, and Pma1 were used as markers for detergent-soluble and detergent-resistant membranes

The markedly punctate distribution in the plasma membrane displayed by Pdr10-GFP has been observed for several other integral plasma membrane proteins. In some cases, these puncta are mobile because they represent proteins (for example, the glucan synthase Fks1) associated with sites where actin-mediated endocytosis occurs ("actin patches") (Utsugi et al. [@CR105]). In other cases, the puncta are immobile because they represent proteins (for example, the arginine permease Can1 and the tetraspanin Sur7) associated with stable, static plasma membrane subdomains such as the MCC compartment (Grossmann et al. [@CR40]; Malinska et al. [@CR74]; Young et al. [@CR114]). Therefore, we examined whether the Pdr10-GFP puncta were stable over time and whether they were affected by inhibition of actin function. We found that treatment of cells with latrunculin A did not disrupt the punctate localization displayed by Pdr10-GFP (Fig. [1](#Fig1){ref-type="fig"}b). Some of the Pdr10-GFP puncta in a typical cell were immobile for at least 20 min (Fig. [1](#Fig1){ref-type="fig"}c). However, other Pdr10-GFP puncta seemed more mobile, particularly in the bud. There is evidence that the mother and bud compartments have distinct properties. For example, PE exposure is reportedly greater at the bud tip than in the mother cell (Iwamoto et al. [@CR49]), and the collar of septin filaments at the bud neck acts as a diffusion barrier to confine certain plasma membrane proteins uniquely in the bud (Takizawa et al. [@CR103]). However, the presence of mobile patches in the mother cell as well indicates that there is a mobile population of Pdr10 throughout the cell. Pdr10-GFP did not behave like an actin patch-associated protein, but the presence of both mobile and immobile populations argues against its exclusive localization to previously defined subdomains of the yeast plasma membrane.

Can1 and other structurally related permeases not only display a punctate distribution in the plasma membrane, but also are found in the detergent-resistant membrane (DRM) fraction (sometimes equated with lipid rafts) when cells are subjected to biochemical fractionation (Malinska et al. [@CR74], [@CR75]). To permit facile examination of the behavior of Pdr10 during biochemical fractionation, we tagged the chromosomal allele of *PDR10* at its C-terminus with c-Myc and His~6~ epitopes in tandem (the mh tag) under control of the native *PDR10* promoter. We then prepared total membranes from such cells, extracted them with cold detergent (Triton X-100), and fractionated them by density gradient flotation. When subjected to this procedure, the residual lipid associated with the DRM fraction causes it to appear at the top of the gradient, while detergent-soluble or aggregated proteins exhibit higher apparent density and are found at the bottom of the gradient (Bagnat et al. [@CR6]; Malinska et al. [@CR74], [@CR75]). Previous studies using this assay have identified the plasma membrane H^+^-ATPase Pma1 and the glycosylphosphatidylinositol (GPI)-anchored protein Gas1 as markers for the DRM fraction (Bagnat et al. [@CR6]; Malinska et al. [@CR74]). Markers for the detergent-soluble fraction of the plasma membrane have proven more controversial: the hexose transporter Hxt1 has been reported to primarily localize to the detergent-soluble fraction by Tanner and colleagues (Malinska et al. [@CR74], [@CR75]), using anti-Hxt1 antisera for detection, but Hxt1-GFP has instead been found in the detergent-resistant fraction by Lauwers and André ([@CR64]) using anti-GFP antisera for detection. These studies also use different strain backgrounds, which may explain the discrepancy. We find that Hxt1 is primarily (\~90%) in the detergent-soluble fraction (Fig. [1](#Fig1){ref-type="fig"}d), in good agreement with the results reported by Tanner and colleagues (Malinska et al. [@CR74], [@CR75]).

To detect the inabundant Pdr10 in flotation gradients, we found that it was necessary to load substantially more material than has typically been reported. Unfortunately, the greater amounts loaded resulted in loss of resolution in the small Optiprep (iodixanol) density gradients pioneered by Simons and colleagues (Bagnat et al. [@CR6]). We therefore developed a modified procedure using a larger gradient with a consequently longer centrifugation (described in detail under [Materials and Methods](#Sec1){ref-type="sec"}). The DRM marker Gas1 exhibits essentially identical behavior in both gradients, as does the chitin synthase Chs3 (data not shown). However, while more than 90% of Pma1 was found in the DRM fraction in the smaller gradients, a substantial amount of Pma1 was instead associated with the soluble fraction in these expanded gradients, with only 25%--50% of Pma1 remaining in the DRM fraction (Fig. [1](#Fig1){ref-type="fig"}d). We have not attempted to ascertain whether this reflects slow solubilization or aggregation of Pma1 in the longer ultracentrifugation procedure we employ, because Gas1 and Hxt1 serve as robust markers for the detergent-resistant and detergent-soluble fractions in this gradient.

Using this procedure, we were able to detect Pdr10-mh with antisera directed against the c-*myc* epitope (Fig. [1](#Fig1){ref-type="fig"}d). Tellingly, Pdr10-mh displayed a distribution quite similar to that of Pma1, with substantial Pdr10-mh residing in the DRM fraction. The presence of both detergent-soluble and detergent-resistant Pdr10 is reminiscent of the presence of immobile and mobile populations of Pdr10-GFP as seen by fluorescence microscopy, but the nature of the DRM experiment precludes assignment of the in vitro populations to in vivo populations (Lichtenberg et al. [@CR69]).

Absence of Pdr10 Causes Distinct Phenotypes {#Sec11}
-------------------------------------------

Among the ABC transporters encoded in the *S. cerevisiae* genome, Pdr10 exhibits the closest homology to Pdr5 (67% identity), Pdr15 (68% identity), and Snq2 (40% identity). All three of the latter are capable of mediating the export of various drugs, antimetabolites, membrane perturbing agents, and other noxious compounds (Balzi et al. [@CR8]; Bissinger and Kuchler [@CR11]; Decottignies et al. [@CR21]; Schüller et al. [@CR95]; Servos et al. [@CR96]; Wolfger et al. [@CR112]). Therefore, we examined whether deletion of the *PDR10* gene would confer enhanced sensitivity to a spectrum of cytotoxic compounds. We also examined whether loss of Pdr10 would further enhance (or otherwise alter) the drug sensitivity of a *pdr5∆* mutant. We found that, in contrast to *pdr5∆* cells, *pdr10∆* cells were not abnormally sensitive to ketoconazole, rhodamine 6G, or cycloheximide (Fig. [2](#Fig2){ref-type="fig"}a), nor did a *pdr5∆ pdr10∆* double mutant differ in its sensitivity from a *pdr5∆* single mutant (Fig. [2](#Fig2){ref-type="fig"}a). The absence of Pdr10 similarly had no effect on the toxicity of itraconazole, oligomycin, amphotericin B, or Crystal Violet, with or without Pdr5 (data not shown). Hence, Pdr10 does not appear to contribute significantly to the capacity of the cell to export such growth-inhibitory compounds.Fig. 2Pdr10 is required for normal response to Calcofluor and sorbate. **a** Spot assays were performed using serial dilutions prepared from overnight cultures of strains W303-1A (wild type), NRY243 (*pdr10∆*), NRY201 (*pdr5∆*), and NRY230 (*pdr5∆ pdr10∆*). All plates were grown for 2 days at 30°C unless otherwise noted. YPD plates contained either 2 μM ketoconazole (keto), 20 μM rhodamine 6G (Rh. 6G), or 100 ng/ml cycloheximide (CHX). **b** Halo assays were performed on YPD plates with various detergents. Aliquots from overnight cultures were diluted into YPD top agar as described under [Materials and Methods](#Sec1){ref-type="sec"}. Top row, strains W303-1A, NRY243, and NRY601 (*pdr10∆ chs3∆*) were assayed with dodecyl maltoside (DDM). Middle row, the same strains were assayed with dodecyl phosphocholine (DPC). Bottom row, strains YPH499 (wild type) and YHW10 N (*pdr10∆*) were assayed with DDM. **c** Spot assays were performed as in A using strains W303-1A, NRY243, and NRY602 (*chs3∆*), NRY601 and NRY608 (*chs6∆*), and NRY610 (*pdr10∆ chs6∆*) on YPD plates (top) or YPD plates containing 6 μg/ml Calcofluor White (CW; middle) or 100 μg/ml Congo Red (CR; bottom). **d** Similar assays were performed using strains W303-1A (wild type), NRY243 (*pdr10∆*), NRY301 (*pdr12∆*), and NRY366 (*pdr10∆ pdr12∆*) on YPD plates buffered to pH 3.5 with 50 mM sodium succinate with or without 4 mM potassium sorbate

We also challenged *pdr10∆* cells with a number of detergents. As judged by a halo assay, a *pdr10∆* mutant strain in the W303 genetic background reproducibly exhibited modestly elevated resistance to detergents containing C~12~ alkyl chains, including dodecyl maltoside and dodecyl phosphocholine (Fig. [2](#Fig2){ref-type="fig"}b, upper two rows). However, a *pdr10∆* mutant in the YPH499 genetic background did not exhibit this effect (Fig. [2](#Fig2){ref-type="fig"}b, lowest row). We therefore used *pdr10∆* cells derived from the W303 lineage for further study.

In addition to changes in membrane composition, changes in cell wall structure can affect the detergent sensitivity displayed by *S. cerevisiae* cells; indeed, cell wall alterations can affect the sensitivity of yeast cells even to a strong anionic detergent like SDS (Bickle et al. [@CR10]; Machi et al. [@CR71]; Santos and Snyder [@CR93]). The yeast cell wall is composed of three types of polymers: mannoproteins, glucan, and chitin (Klis et al. [@CR57]; Lesage and Bussey [@CR67]). We found (Fig. [2](#Fig2){ref-type="fig"}c) that *pdr10∆* mutants were abnormally sensitive to two agents, Calcofluor White and Congo Red, that inhibit the growth of cells that have abnormally high amounts of chitin (Roncero et al. [@CR90]). In contrast, otherwise isogenic wild-type cells (Fig. [2](#Fig2){ref-type="fig"}c), or cells expressing either Pdr10-GFP or Pdr10-mh from the chromosomal *PDR10* locus (data not shown), did not display such hypersensitivity (and, thus, both Pdr10-GFP and Pdr10-mh are functional). If the sensitivity of the *pdr10∆* cells is due to abnormal chitin, then we expected that sensitivity to Calcofluor White might be ameliorated by compromising chitin production. The chitin synthase responsible for producing the majority of the chitin generated in a vegetatively growing cell is Chs3, but cells can survive in its absence due to the function of the homologous chitin synthase Chs2 (Cabib [@CR13]). Chs3 is normally delivered to the plasma membrane via the action of dedicated escort factors, including Chs6 (Valdivia et al. [@CR107]; Valdivia and Schekman [@CR106]). Consistent with the conclusion that the Calcofluor White sensitivity of *pdr10∆* cells arises from elevated cell wall chitin, we found that *pdr10∆ chs3∆* and *pdr10∆ chs6∆* double mutants were not hypersensitive to Calcofluor White (Fig. [2](#Fig2){ref-type="fig"}c). Likewise, in the W303 strain background, a *pdr10∆chs3∆* double mutant was not detergent resistant (Fig. [2](#Fig2){ref-type="fig"}b, upper rows). These findings indicate that both the Calcofluor White sensitivity and the detergent resistance displayed by *pdr10∆* cells are largely due to enhanced chitin production by the integral membrane protein Chs3 in the absence of this ABC transporter.

Although Pdr10 shares its highest degree of homology with Pdr5 and Pdr15, it is also closely related to other ABC transporters in the *S. cerevisiae* genome, including Pdr12 (36% identity to Pdr10). Pdr12 is located in the plasma membrane and is responsible for the export of weak organic acids (Piper et al. [@CR83]). Consequently, *pdr12∆* mutants are hypersensitive to the growth inhibitory action of weak organic acids used as food preservatives (e.g., sorbate or benzoate) (Piper et al. [@CR83]). We found that *pdr10∆* cells exhibited weak resistance to sorbate (Fig. [2](#Fig2){ref-type="fig"}d); however, this behavior required the function of Pdr12, because the modest sorbate resistance observed was eliminated in a *pdr10∆ pdr12∆* double mutant (Fig. [2](#Fig2){ref-type="fig"}d). Thus, here, too, the absence of Pdr10 somehow promoted the function of a sister integral membrane protein, Pdr12.

Taken together, these results suggested that the function of Pdr10 contributes to the normal expression, and/or sorting and trafficking, and/or catalytic competence of Chs3 and Pdr12. To determine whether this phenotype was unique to the loss of Pdr10, we examined the Calcofluor White and sorbate sensitivity of yeast strains lacking other members of the *S. cerevisiae* ABC transporter family known to reside in the plasma membrane. Although comparable sorbate resistance was observed in *pdr15∆* cells and comparable Calcofluor White sensitivity was observed in cells lacking the putative, but uncharacterized, ABC transporter encoding by the *YOL075c* locus*,* the combination of Calcofluor White sensitivity and sorbate resistance was only observed in *pdr10∆* cells (Fig. [3](#Fig3){ref-type="fig"}). Thus, Pdr10 uniquely has a role in maintaining the proper level, maturation, localization, and/or function of both Chs3 and Pdr12.Fig. 3Calcofluor sensitivity and sorbate resistance define a specific *pdr10∆* phenotype. Serial dilutions of overnight cultures of strains W303-1A (wild type), NRY243 (*pdr10∆*), NRY201 (*pdr5∆*), NRY212 (*pdr15∆*), NRY336 (*pdr18∆*), NRY334 (*YOL075c∆*), and WKK7 (*ste6∆*) were spotted onto YPD plates containing 6 μg/ml Calcofluor White (CW; *left column*) or 4 mM sorbate (*right column*)

Pdr10 Is Required for Normal Endocytic Trafficking of Chs3 {#Sec12}
----------------------------------------------------------

To distinguish among these possibilities, we first examined the effect of a *pdr10∆* mutation on the function and localization of Chs3. To confirm that *pdr10∆* cells do produce abnormally high levels of chitin, we examined cells by fluorescence microscopy after staining with Calcofluor White. Indeed, we found that, compared to otherwise isogenic *PDR10*^+^ control cells, *pdr10∆* cells exhibited brighter fluorescence and therefore excess chitin, while cell wall chitin was almost entirely eliminated when Chs3 was absent (Fig. [4](#Fig4){ref-type="fig"}a). Elevated chitin production could arise from increased Chs3, more active Chs3, or aberrant localization of Chs3. As mentioned already, normal anterograde trafficking of Chs3 to the plasma membrane requires additional protein factors, including Chs6 (Valdivia and Schekman [@CR106]), and we found that, like a *chs3∆* mutation, a *chs6∆* mutation also eliminated the Calcofluor White sensitivity of *pdr10∆* cells (Fig. [2](#Fig2){ref-type="fig"}c). Therefore, the elevated chitin production of *pdr10∆* cells does not occur because the normal pathway for transport of Chs3 to the plasma membrane is bypassed when Pdr10 is absent.Fig. 4Defective endocytosis of Chs3 causes excess chitin deposition in *pdr10∆* cells. **a** Cells from log phase cultures of strains W303-1A (wild type), NRY243 (*pdr10∆*), NRY602 (*chs3∆*), and NRY601 (*pdr10∆ chs3∆*) were stained for chitin and examined by fluorescence microscopy. Bar, 4 μm. **b** Log phase cells from strains W303-1A and NRY251 (*pdr10*∆) carrying plasmids pRS315-CHS7 and pCRP12 were treated with 3.6 μM α-factor for 35 min in SCD buffered to pH 3.5 with 25 mM sodium succinate and supplemented with adenine. Pheromone was then washed out at time 0, and the localization of Chs3-GFP was monitored by fluorescence microscopy as described under [Materials and Methods](#Sec1){ref-type="sec"}. Punctate Chs3-GFP staining of the plasma membrane in *pdr10∆* cells at late time points is indicated by *arrow heads*. Bar, 3 μm. **c** Strains W303-1A, NRY243, and NRY407 (*cho1∆*) were grown into log phase, stained for chitin, and examined by fluorescence microscopy. Bar, 5 μm. **d** Serial dilutions of overnight cultures of strains W303-1A, NRY243, and NRY407 were spotted onto YPD plates containing Calcofluor

In vegetatively growing cells, Chs3 cycles between the trans-Golgi network and endosomal compartments during most of the cell cycle (Valdivia et al. [@CR107]) but displays significant accumulation at the plasma membrane primarily at the small-bud stage (Chuang and Schekman [@CR17]). The intracellular pool of Chs3 can also be redistributed to the plasma membrane after treatment of cells with mating pheromone, an effect we exploited to trap Chs3 at the plasma membrane in wild-type and *pdr10∆* cells. Upon washout of pheromone, cells re-entered the cell cycle and Chs3 moved to the bud neck, as expected (Fig. [4](#Fig4){ref-type="fig"}b). At later time points, Chs3 was efficiently internalized in wild-type cells, whereas in *pdr10∆* cells a small amount of Chs3-GFP persisted in discrete patches at the plasma membrane, even though the majority was intracellular. Thus, in *pdr10∆* cells, endocytosis of Chs3 was somewhat less efficient than in wild-type cells (although this block was by no means complete). The prolonged residence time of Chs3 at the plasma membrane in *pdr10∆* cells could well explain the increased amount of chitin produced in these cells.

We were interested in determining whether this modest endocytic defect of *pdr10∆* cells was specific for Chs3 or was more general. We therefore examined endocytic uptake of two fluorescent dyes, Lucifer Yellow and FM 4-64 (Fig. [5](#Fig5){ref-type="fig"}a). These dyes serve as markers for fluid phase endocytosis and bulk membrane internalization, respectively, with both being internalized to the vacuole. Uptake of both of these markers was normal in *pdr10∆* cells, demonstrating that the partial block in Chs3 endocytosis is not a general effect on all endocytic processes. We also examined actin morphology in these cells (Fig. [5](#Fig5){ref-type="fig"}b), because an intact actin cytoskeleton is a prerequisite for endocytosis in yeast (Ayscough et al. [@CR4]; Kubler and Riezman [@CR61]). Deletion of *PDR10* had no apparent effect on actin localization or on its polarization in small-budded cells (Fig. [5](#Fig5){ref-type="fig"}b).Fig. 5Pdr10 is not required for bulk endocytosis or actin morphology. **a** Strains W303-1A (wild type) and NRY243 (*pdr10∆*) were grown to log phase, incubated with Lucifer Yellow or FM 4-64 as a marker for endocytosis, and examined by fluorescence microscopy. **b** Strains W303-1A and NRY243 were grown to log phase, permeabilized, and stained with rhodamine-phalloidin to visualize actin by fluorescence microscopy. All bars, 5 μm

Lack of Dnf1 and Dnf2 Results in Defective Endocytosis of Chs3 {#Sec13}
--------------------------------------------------------------

If the partial defect in endocytosis of Chs3 in a *pdr10∆* mutant is responsible for its elevated chitin production and thus its increased sensitivity to Calcofluor White, then other mutations or conditions that influence the efficiency of Chs3 endocytosis should elicit the same phenotype. Interestingly, we found that a *cho1∆* strain, which lacks phosphatidylserine synthase (Atkinson et al. [@CR2], [@CR3]; Kiyono et al. [@CR56]; Kohlwein et al. [@CR58]; Letts et al. [@CR68]), displayed even greater chitin deposition (Fig. [4](#Fig4){ref-type="fig"}c) and an even higher sensitivity to Calcofluor White than the *pdr10∆* strain (Fig. [4](#Fig4){ref-type="fig"}d). Quantitation of chitin deposition indicated that *pdr10∆* cells had approximately 1.9-fold more chitin in their cell walls than wild-type cells, while *cho1∆* cells had approximately 3.8-fold more chitin. We have not yet examined directly the localization of Chs3-GFP in *cho1∆* cells; however, these data suggested that membrane composition might be important in Chs3 endocytosis and thus that the absence of Pdr10 might influence plasma membrane lipid distribution. We therefore examined sterol localization in wildtype and *pdr10∆* cells by staining with filipin (Fig. [6](#Fig6){ref-type="fig"}a), finding little difference between those two strains. Simons and colleagues have reported that treatment with mating pheromone polarizes sterols to the site of polarized growth (the shmoo tip) (Bagnat and Simons [@CR5]), and we find that this process proceeds normally in *pdr10∆* cells as well (Fig. [6](#Fig6){ref-type="fig"}a).Fig. 6Increased phosphatidylethanolamine is accessible to TNBS labeling in *pdr10∆* cells. **a** Strains W303-1A and NRY243 were grown to log phase, incubated with or without α-factor, and then stained with filipin to visualize sterols by fluorescence microscopy. Bar, 5 μm. **b** Exposure of endogenous aminophospholipids to TNBS was assayed with cells grown overnight in the presence of ^32^P-phosphate as described under [Materials and Methods](#Sec1){ref-type="sec"}. Strains used were W303-1A (wild type), NRY243 (*pdr10∆*), NRY549 (*lem3∆*), NRY551 (*pdr10∆ lem3∆*), NRY427 (*dnf1∆ dnf2∆*), and NRY558 (*pdr10∆ dnf1∆ dnf2∆*)

It has been proposed that proper maintenance of membrane asymmetry is important for endocytosis at low temperatures and that Pdr5 and another ABC transporter, Yor1, are candidate outward-directed PE translocases (Pomorski et al. [@CR84]). Moreover, *pdr5∆ pdr15∆* cells exhibit increased accessibility of PE to the small-molecule reagent TNBS (Schüller et al. [@CR95]), which is able to pass through the cell wall. TNBS labeling has been used to assess exposure of PE and PS on the outer leaflet of the plasma membrane (Gordesky and Marinetti [@CR38]; Pomorski et al. [@CR84]; Siegmund et al. [@CR99]), although subcellular fractionation data raise the possibility that there is considerable leakage of the reagent into the secretory pathway (Pomorski et al. [@CR84]). We analyzed the total phospholipid composition (Table [2](#Tab2){ref-type="table"}) and accessibility of aminophospholipids to TNBS (Fig. [6](#Fig6){ref-type="fig"}b) in wild-type and *pdr10∆* cells grown on ^32^P-phosphate. We found that a *pdr10∆* mutation had no discernible effect on overall phospholipid composition (Table [2](#Tab2){ref-type="table"}), but caused a significant increase in the fraction of the PE that was accessible to TNBS labeling (Fig. [6](#Fig6){ref-type="fig"}b). Thus, *pdr10∆* plasma membranes either are significantly more permeable to TNBS or exhibit a defect in maintenance of plasma membrane asymmetry.

The ABC transporters with established transport activities that are most closely related to Pdr10, including Pdr5 and Snq2, mediate outward-directed lipid transport and/or export of xenobiotics from the cell (Balzi et al. [@CR8]; Bissinger and Kuchler [@CR11]; Decottignies et al. [@CR21]; Egner et al. [@CR29]; Mahé et al. [@CR72]; Pomorski et al. [@CR84]; Schüller et al. [@CR95]). If Pdr10 had a similar function, then loss of Pdr10 should reduce, not increase, the fraction of PE that is surface-exposed. In contrast, if the absence of Pdr10 somehow indirectly crippled the function of the inward-directed PE translocases, then the biochemical phenotype observed in *pdr10∆* cells would be more readily explained. In support of this, we observed that the level of PE accessible to TNBS labeling in *pdr10∆* cells was comparable to that in cells in which the genes for both putative inward-directed plasma membrane PE translocases, *DNF1* and *DNF2,* were deleted (Fig. [6](#Fig6){ref-type="fig"}b); similar results were also obtained for cells lacking the *LEM3* gene, which encodes an integral membrane protein that is required for exit of Dnf1 and Dnf2 from the endoplasmic reticulum (Saito et al. [@CR91]). Furthermore, no additive increase in exposure of PE was observed in *pdr10∆ lem3∆* or *pdr10∆ dnf1∆ dnf2∆* strains (Fig. [6](#Fig6){ref-type="fig"}b). The overall phospholipid compositions of all of these strains were quite comparable (Table [2](#Tab2){ref-type="table"}). The absence of any additive or synergistic effect of the *dnf1∆dnf2∆* (or *lem3∆*) mutations in a *pdr10∆* mutant demonstrated that *pdr10∆* phenocopied *dnf1∆ dnf2∆.* That is, regardless of whether TNBS labeling is measuring PE exposure on the outer leaflet or permeability, the loss of Pdr10 function mimicked the loss of Dnf1 and Dnf2 function in these cells.

We were interested in whether this might reflect a direct role for Pdr10 in the synthesis, sorting, or activity of the inward-directed translocases. Therefore, we examined the level of expression and the localization of Dnf1, Dnf2, and Lem3 in *pdr10∆* cells by constructing functional chromosomal GFP fusions (tests for functionality described under [Materials and Methods](#Sec1){ref-type="sec"}). Dnf1-GFP, Dnf2-GFP, and Lem3-GFP were all readily detectable by fluorescence microscopy, present at equivalent levels, and exhibited the expected punctate pattern in the plasma membrane in both wild-type and *pdr10∆* cells (Fig. [7](#Fig7){ref-type="fig"}). There were no discernible differences in the localization of any of these three proteins between wild-type and *pdr10∆* cells. Likewise, a functional Pdr5-GFP chimera expressed from the chromosomal *PDR5* locus was localized to the plasma membrane indistinguishably in wild-type and *pdr10∆* cells (Fig. [7](#Fig7){ref-type="fig"}). Putative inward- and outward-directed translocases were thus present at normal levels and were properly localized to the plasma membrane in *pdr10∆* cells.Fig. 7Pdr10 is not required for normal localization of putative PE translocases. Strains NRY914 (wild type, Lem3-GFP), NRY918 (*pdr10∆*, Lem3-GFP), NRY921 (wild type, Dnf1-GFP), NRY932 (*pdr10∆*, Dnf1-GFP), NRY923 (wild type, Dnf2-GFP), NRY929 (*pdr10∆*, Dnf2-GFP), NRY906 (wild type, Pdr5-GFP), and NRY916 (*pdr10∆*, Pdr5-GFP) were grown to log phase, and the indicated proteins were visualized by fluorescence microscopy. Collages of representative images are shown. Bar, 6 μm

To assess whether inward-directed translocase activity was still present in *pdr10∆* cells, we examined the uptake of an exogenously supplied fluorescent PE surrogate, NBD-PE (Kean et al. [@CR52]), in wild-type and *pdr10∆* cells (Fig. [8](#Fig8){ref-type="fig"}). It has been reported previously that it is possible to observe specific, translocase-dependent internalization of NBD-labeled lipids at low temperature, which prevented background internalization due to endocytosis (Grant et al. [@CR39]). However, in our hands, both wild-type and *pdr10∆* cells were still able to internalize modest amounts of NBD-PE to discrete intracellular puncta at low temperature, indicating either that endocytosis was not completely blocked in our hands or that a low level of membrane leakage was occurring (data not shown). We therefore examined NBD-PE uptake in the presence of latrunculin A, which disrupts the actin cytoskeleton and hence blocks endocytosis (Ayscough et al. [@CR4]; Pomorski et al. [@CR84]). We found that *pdr10∆* cells exhibited no defect compared to wild-type cells. *dnf1∆ dnf2∆* cells also exhibited no defect in NBD-PE internalization under these conditions (Fig. [8](#Fig8){ref-type="fig"}), perhaps because the homologous P-type ATPase Drs2 can relocalize to the plasma membrane upon latrunculin treatment (Liu et al. [@CR70]). Strikingly, however, *lem3∆* cells were unable to internalize NBD-PE under these conditions, with or without the presence of Pdr10. These data demonstrate that Lem3 must have functions other than its role in the biogenesis of Dnf1 and Dnf2, perhaps in forward transport of Drs2 to the plasma membrane. Neither *pdr10∆* nor *lem3∆* had any effect on uptake of a fluorescent ceramide surrogate, NBD-Cer (Fig. [8](#Fig8){ref-type="fig"}). Taken together, these results demonstrate the presence of normal amounts of Dnf1, Dnf2, and Lem3 in *pdr10∆* plasma membranes and demonstrate that *pdr10∆* cells are still capable of PE internalization. It is known that mutations in a number of genes implicated in vesicular trafficking produce altered plasma membrane asymmetry as a secondary effect (Chen et al. [@CR16]; Parsons et al. [@CR82]), so it seems likely that increased accessibility of PE to TNBS labeling in *pdr10∆* cells is such an indirect consequence.Fig. 8*pdr10∆* cells internalize NBD-PE in a Lem3-dependent manner. Strains W303-1A (wild type), NRY243 (*pdr10∆*), NRY549 (*lem3∆*), NRY551 (*pdr10∆ lem3∆*), NRY427 (*dnf1∆ dnf2∆*), and NRY558 (*pdr10∆ dnf1∆ dnf2∆*) were grown to log phase, treated with latrunculin A to block endocytosis, and incubated with the fluorescent reporter lipid NBD-PE or NBD-Cer as described under [Materials and Methods](#Sec1){ref-type="sec"}. Cells were examined by fluorescence microscopy and differential interference contrast microscopy (DIC). Bar, 6 μm

Dnf1 and Dnf2 have been implicated in endocytosis at low temperatures (Furuta et al. [@CR35]; Pomorski et al. [@CR84]), in keeping with a broader role for members of this transporter family in vesicular trafficking (Chen et al. [@CR16]). Given that the PE exposure caused by a *pdr10∆* mutation was quite comparable to that caused by *dnf1∆ dnf2∆* double deletion, the mild defect in endocytic trafficking we observed for Chs3 in *pdr10∆* cells might also be associated with *dnf1∆ dnf2∆* or *lem3∆* cells. Indeed, we found that cells lacking both Dnf1 and Dnf2 were sensitive to Calcofluor White (Fig. [9](#Fig9){ref-type="fig"}a), exhibited increased chitin in their cell wall (Fig. [9](#Fig9){ref-type="fig"}b), and were equivalent to *pdr10∆* cells in both respects. Moreover, a *pdr10∆ dnf1∆ dnf2∆* triple mutant strain did not display any increase in Calcofluor sensitivity or chitin deposition compared to the otherwise isogenic *pdr10∆* single mutant or the *dnf1∆ dnf2∆* double mutant (Fig. [9](#Fig9){ref-type="fig"}a, b), with all mutant strains exhibiting a 1.8- to 1.9-fold increase in chitin deposition. This lack of synergy was not due to any limitation in the capacity of these assays to detect such potentiation, because *cho1∆* cells exhibited much higher Calcofluor White sensitivity and chitin deposition than *pdr10∆* cells (Fig. [4](#Fig4){ref-type="fig"}). Moreover, *lem3∆* cells were also more sensitive to Calcofluor White than *pdr10∆* or *dnf1∆ dnf2∆* cells (Fig. [9](#Fig9){ref-type="fig"}a), which is reminiscent of the more profound effect of this mutation on NBD-PE uptake (Fig. [8](#Fig8){ref-type="fig"}). Taken together, these results show that *pdr10∆* cells exhibit a modest defect in endocytosis of Chs3, that this mimics a phenotype of *dnf1∆ dnf2∆* cells, and that Pdr10 is not required for expression or localization of Dnf1, Dnf2, and Lem3. We have not been able to elucidate the molecular basis for this defect in Chs3 trafficking.Fig. 9Loss of Dnf1 and Dnf2 function in *pdr10∆* cells is associated with their increased chitin deposition. **a** Serial dilutions from overnight cultures of strains W303-1A (wild type), NRY243 (*pdr10∆*), NRY427 (*dnf1∆ dnf2∆*), NRY558 (*pdr10∆ dnf1∆ dnf2∆*), NRY549 (*lem3∆*), and NRY551 (*pdr10∆ lem3∆*) were spotted onto YPD plates at increasing concentrations of Calcofluor White (CW). **b** Log phase cultures of strains W303-1A, NRY243, NRY427, and NRY558 were stained for chitin and examined by fluorescence microscopy. Bar, 5 μm. **c** Serial dilutions of strains W303-1A, NRY243, NRY549, and NRY551 were spotted onto YPD plates buffered to pH 3.5 with sodium succinate and containing potassium sorbate. **d** Serial dilutions of strains W303-1A, NRY243, NRY301 (*pdr12∆*), and NRY366 (*pdr10∆ pdr12∆*) were spotted onto YPD plates containing Calcofluor White

Complex Interplay Among Pdr10, Lem3, and Pdr12 {#Sec14}
----------------------------------------------

Cells lacking Pdr10 also exhibit a modest increase in their resistance to sorbate that requires the sorbate transporter, Pdr12 (Fig. [2](#Fig2){ref-type="fig"}d). We were interested in whether this was also a phenotype of *dnf1∆ dnf2∆* cells or *lem3∆* cells. Interestingly, we found not only that *lem3∆* cells were not sorbate resistant, but that a *lem3∆* mutation eliminated the modest sorbate resistance conferred by the *pdr10∆* mutation; no such epistasis was found with the *dnf1∆ dnf2∆* double mutant (Fig. [9](#Fig9){ref-type="fig"}c and data not shown). Thus, the apparent increase in Pdr12 action found in cells lacking Pdr10 does not mimic a defect found in *dnf1∆ dnf2∆* or *lem3∆* cells but, rather, requires the presence of functional Lem3.

Cells lacking Pdr10 exhibit increased sensitivity to the chitin-directed agent, Calcofluor White (Fig. [2](#Fig2){ref-type="fig"}c), and that is not further enhanced by the absence of Dnf1 and Dnf2 (Fig. [9](#Fig9){ref-type="fig"}a). Strikingly, as observed for the sorbate resistance of *pdr10∆* cells, we found that loss of Pdr12 eliminated the Calcofluor White sensitivity of *pdr10∆* (Fig. [9](#Fig9){ref-type="fig"}d). We also found that the introduction of a *pdr12∆* mutation into *pdr10∆* cells substantially reduced the accessibility of PE to TNBS labeling (Table [2](#Tab2){ref-type="table"}). Collectively, these findings indicate complex interactions among Pdr10, Pdr12, and Lem3, which produce secondary effects on Chs3 endocytosis.

Pdr10 Action Excludes Pdr12 from the Detergent-Resistant Membrane Fraction {#Sec15}
--------------------------------------------------------------------------

To see whether a clearer molecular function could be assigned to Pdr10, we examined whether loss of Pdr10 affects the level and/or localization of Pdr12. When equivalent amounts of plasma membrane protein were resolved by SDS-PAGE and analyzed by immunoblotting, we found that, compared to otherwise isogenic control cells, *pdr10∆* mutant cells exhibited a reproducible, approximately twofold increase in the amount of Pdr12 relative to wild-type cells, whereas there was no significant difference between wild-type and *pdr10∆* cells in the content of numerous other membrane proteins in the same samples (Fig. [10](#Fig10){ref-type="fig"}a). Visualization of functional Pdr12-GFP expressed from the *PDR12* locus in wild-type and *pdr10∆* cells confirmed that Pdr12-GFP expression was elevated in the *pdr10∆* mutant cells (Fig. [10](#Fig10){ref-type="fig"}b), but we could distinguish no obvious difference in localization. In both wild-type and *pdr10∆* cells, the Pdr12-GFP was observed throughout the plasma membrane in a readily observable punctate pattern. Approximately 30% of cells in both strains also exhibited some intracellular punctate staining (data not shown), with most such cells also exhibiting plasma membrane Pdr12-GFP. The level of *PDR12* mRNA in *pdr10∆* cells was not different from that in *PDR10*^*+*^ control cells, as judged by global transcriptome analysis using hybridization to DNA microarrays (S. Shtivelman, N. C. Rockwell, and J. Thorner, unpublished data). Thus, the increase in Pdr12 found in *pdr10∆* cells could not be attributed to any change in transcription, and therefore the elevation of plasma membrane Pdr12 in *pdr10∆* cells most likely results from a reduced rate of turnover rather than a faster rate of synthesis. The latter might occur if compartmentation of Pdr12 was altered in *pdr10∆* cells in a manner that was not revealed at the level of fluorescence microscopy.Fig. 10*pdr10∆* cells accumulate excess Pdr12 in the plasma membrane. **a** Total membranes were prepared from log phase cultures of strains W303-1A (wild type) and NRY243 (*pdr10∆*). The indicated proteins were detected by immunoblotting, with equal protein loaded for each strain. **b** Strains NRY915 (wild type) and NRY925 (*pdr10∆*) were grown to log phase in YPD, and Pdr12-GFP was examined by fluorescence microscopy. A collage of representative images is shown. Pdr12-GFP function was confirmed by sorbate sensitivity. Bar, 6 μm

When membranes are subjected to biochemical fractionation, a readily detectable amount of Pdr10 is associated with the DRM fraction (Fig. [1](#Fig1){ref-type="fig"}d). Hence, we also examined the distribution of Pdr12 in this assay. Strikingly, we found that approximately 60% of the total pool of Pdr12 was associated with the DRM fraction in membranes from *pdr10∆* cells, whereas in the membranes from wild-type cells approximately one-third of the total Pdr12 was present in the DRM fraction and more than 50% was present in the detergent-soluble fraction (Fig. [11](#Fig11){ref-type="fig"} and Table [3](#Tab3){ref-type="table"}). The Pdr10-dependent shift observed for Pdr12 was in contrast to Chs3 and Gas1 (Bagnat et al. [@CR6]; Nuoffer et al. [@CR80]), whose distributions were unaltered by loss of Pdr10 (Fig. [11](#Fig11){ref-type="fig"} and Table [3](#Tab3){ref-type="table"}). Association of Lem3 and Pdr5 with the DRM fraction was slightly higher in *pdr10∆* cells than in the wild type (Table [3](#Tab3){ref-type="table"}), but this effect was too small to be statistically significant. Thus, our data indicate a novel role for Pdr10 as a negative regulator of the partitioning of Pdr12 into the DRM fraction; that is, Pdr10 must regulate the local environment of Pdr12 in some manner that alters its solubilization properties in the presence of detergent.Fig. 11*pdr10∆* cells accumulate Pdr12 in the detergent-resistant membrane fraction. **a** Total membranes from log phase cultures of strains W303-1A or NRY904 (wildtype) and NRY243 or NRY908 (*pdr10∆*) were examined by cold detergent extraction, Optiprep density gradient flotation, and immunoblotting for the indicated proteins. Strains NRY904 and NRY908 contain Lem3 C-terminally tagged with a tandem myc-His~6~ (mh) tag. In vivo function of the resulting Lem3-mh protein was confirmed by Calcofluor sensitivity. **b** Immunoblotting data were quantitated, and the percentage of total Pdr12 (*left*) and Chs3 (*right*) associated with detergent-resistant and detergent-soluble fractions is presented as the mean value for four independent experiments, with error bars representing the standard deviation. Detergent-resistant and detergent-soluble membranes were defined as fractions 1--3 and 7--9, respectively, in the Optiprep density gradientsTable 3Association of membrane proteins with the detergent-resistant membrane fraction^a^ProteinWild type*pdr10∆*% DRM% Soluble% DRM% SolublePdr1233 ± 1154 ± 1061 ± 628 ± 11Chs317 ± 962 ± 619 ± 956 ± 10Lem3-mh19 ± 575 ± 724 ± 472 ± 1Gas147 ± 537 ± 145 ± 236 ± 2Pdr557 ± 1123 ± 1069 ± 914 ± 8*Note*: Membranes were prepared and analyzed by cold Triton X-100 extraction, Optiprep density gradient flotation, and quantitative immunoblotting as described under [Materials and Methods](#Sec1){ref-type="sec"}. For Pdr12 and Chs3, results are based on four independent experiments. All other proteins were examined at least twice. Strains were W303-1A or NRY904 (wild type with or without chromosomally mh*-*tagged Lem3) and NRY243 or NRY908 (*pdr10∆* with or without chromosomally mh*-*tagged Lem3)

We were also interested in whether Pdr10 function was redundant with that of its two closest homologues, Pdr5 and Pdr15. As one means to examine possible redundancy of this sort among Pdr10, Pdr5, and Pdr15, we examined their genetic interactions using Calcofluor White sensitivity and sorbate resistance. A *pdr5∆* mutation eliminated both the Calcofluor White sensitivity and the mild sorbate resistance of *pdr10∆* cells (Fig. [12](#Fig12){ref-type="fig"}a). *pdr5∆ pdr10∆* cells also exhibited significantly lower TNBS labeling of PE (Table [2](#Tab2){ref-type="table"}) and normal levels of Pdr12 (Fig. [12](#Fig12){ref-type="fig"}c). In contrast, a *pdr15∆* mutation had no discernible effect on *pdr10∆* phenotypes (Fig. [12](#Fig12){ref-type="fig"}a).Fig. 12Pdr5 and phosphosphingolipids are required for *pdr10∆* phenotypes. **a** Serial dilutions of overnight cultures of strains W303-1A (wild type), NRY243 (*pdr10∆*), NRY201 (*pdr5∆*), NRY230 (*pdr5∆ pdr10∆*), NRY212 (*pdr15∆*), NRY236 (*pdr10∆ pdr15∆*), NRY410 (*ipt1∆*), NRY534 (*pdr10∆ ipt1∆*), NRY409 (*sur1∆*), and NRY526 (*pdr10∆ sur1∆*) were spotted onto YPD plates containing Calcofluor White (CW; *left column*) or sorbate buffered with sodium succinate (*right column*). **b** Strains W303-1A, NRY243, NRY409, and NRY526 were assayed for PE accessibility to TNBS labeling after overnight labeling with ^32^P-phosphate as described under [Materials and Methods](#Sec1){ref-type="sec"}. **c** Total Pdr12 and Chs3 levels were examined by immunoblotting equal amounts of total membrane proteins isolated from log phase cultures of strains W303-1A, NRY230, and NRY526. **d** Strains W303-1A, NRY243, NRY409, NRY526, NRY410, and NRY534 were grown to log phase, stained for chitin, and examined by fluorescence microscopy. Bar, 5 μm

Interaction Between Pdr10 Function and Sphingolipids {#Sec16}
----------------------------------------------------

Sphingolipids are known to be important factors for lateral segregation and DRM formation in yeast membranes (Bagnat et al. [@CR6]). We were therefore interested in the interplay between sphingolipid composition and Pdr10 function, because of its role as a negative regulator of Pdr12 association with the DRM fraction. In *S. cerevisiae,* the headgroups of mature sphingolipids contain inositol phosphate. Inositol phosphate is added to ceramide by Aur1, producing inositolphosphorylceramide (IPC). *AUR1* is an essential gene, demonstrating that IPC or lipids derived from IPC are essential (Nagiec et al. [@CR77]). IPC is converted to mannosyl-inositolphosphoryl-ceramide (MIPC) by the redundant action of Sur1 (also known as Csg1) and Csh1 (Beeler et al. [@CR9]; Uemura et al. [@CR104]). MIPC is then converted to mannosyl-di(inositolphosphoryl)-ceramide (M\[IP\]~2~C) by the subsequent action of Ipt1 (Dickson et al. [@CR25]).

Both *sur1∆* and *ipt1∆* mutations were epistatic to *pdr10∆* for both Calcofluor White sensitivity and sorbate resistant (Fig. [12](#Fig12){ref-type="fig"}a). Thus, deletion of genes required for synthesis of mature sphingolipid headgroups ablated the phenotypes of *pdr10∆* cells, even though *pdr10∆* cells did not exhibit significant changes either in the level of total phosphosphingolipid (Table [2](#Tab2){ref-type="table"}) or in the composition of phosphosphingolipids (Table [4](#Tab4){ref-type="table"}). However, *sur1∆* and *ipt1∆* cells exhibited significant changes in sphingolipid composition whether Pdr10 was present or absent, as expected (Table [4](#Tab4){ref-type="table"}). *pdr10∆ sur1∆* cells did not display abnormally high TNBS labeling of PE (Fig. [12](#Fig12){ref-type="fig"}b and Table [2](#Tab2){ref-type="table"}) and contained normal levels of Pdr12 (Fig. [12](#Fig12){ref-type="fig"}c). Furthermore, both *sur1∆* and *ipt1∆* eliminated the elevated chitin deposition caused by a *pdr10∆* mutation (Fig. [12](#Fig12){ref-type="fig"}d). Taken together, these results demonstrate that the aberrant accumulation of Pdr12 and defective endocytosis of Chs3 that occur in *pdr10∆* cells require the presence of mannosylphosphosphingolipids.Table 4Composition of mature sphingolipidsStrainIPCMIPCM(IP)~2~CWild type35 ± 417 ± 247 ± 4*pdr10∆*41 ± 218 ± 241 ± 1*sur1∆*61 ± 313 ± 126 ± 3*ipt1∆*46 ± 348 ± 27 ± 1*Note*: Strains were W303-1A (wild type), NRY243 (*pdr10∆*), NRY409 (*sur1∆*), and NRY410 (*ipt1∆*)*.* Sphingolipids were labeled with ^32^P-phosphate, extracted, and analyzed as described under [Materials and Methods](#Sec1){ref-type="sec"}

Discussion {#Sec17}
==========

We have shown that the ABC transporter Pdr10 is a plasma membrane protein that plays a role in maintaining the proper distribution and function of a subset of other membrane proteins in the yeast *S. cerevisiae.* In the absence of Pdr10, yeast cells exhibit a modest defect in the endocytosis of the chitin synthase Chs3, resulting in increased cell wall chitin and consequent sensitivity to Calcofluor White. The increased chitin deposition and Calcofluor sensitivity are equivalent to those seen in *dnf1∆dnf2∆* cells, which lack the putative inward-directed PE translocases of the yeast plasma membrane (Pomorski et al. [@CR84]). Both *pdr10∆* cells and *dnf1∆dnf2∆* cells exhibit increased accessibility of PE to TNBS labeling, consistent with a defect in maintenance of plasma membrane asymmetry. However, Dnf1 and Dnf2 are present at normal levels in *pdr10∆* cells, and these cells are able to internalize NBD-PE. It thus seems likely that these phenotypes of *pdr10∆* cells arise indirectly, perhaps as a consequence of a modest defect in trafficking of plasma membrane proteins.

The absence of Pdr10 function also results in increased resistance to the weak organic acid sorbate. Sorbate is directly exported from yeast cells by the plasma membrane ABC transporter Pdr12, itself a Pdr10 paralogue. We have shown that *pdr10∆* cells accumulate higher levels of Pdr12, despite no changes in *PDR12* transcription. Additionally, we have shown that the behavior of Pdr12 upon detergent extraction is altered in *pdr10∆* membranes: while Pdr12 in wild-type membranes is mainly in the detergent-soluble fraction, it is mainly in the DRM fraction in *pdr10∆* membranes. There are complex interactions among *PDR10, PDR12,* and *LEM3,* because *pdr12∆* is epistatic to *pdr10∆* for Calcofluor sensitivity and for TNBS labeling of PE, while *lem3∆* is epistatic to *pdr10∆* for sorbate resistance. By contrast, the *dnf1∆ dnf2∆* double mutant is equivalent to *pdr10∆* for Chs3-related phenotypes, with no additive effect in the *pdr10∆ dnf1∆ dnf2∆* triple mutant, but does not affect the Pdr12-related phenotype of sorbate resistance. Moreover, *pdr5∆* is epistatic to *pdr10∆* for both phenotypes. Pdr5, Pdr12, and Lem3 thus seem to be proteins intimately linked to the molecular function of Pdr10. Interestingly, *sur1∆* and *ipt1∆,* which lack genes required for elaboration of sphingolipid headgroups, are epistatic to *pdr10∆* for Calcofluor sensitivity, chitin deposition, sorbate resistance, Pdr12 accumulation, and TNBS labeling of PE. The aberrant behavior of *pdr10∆* membranes thus requires at least three specific proteins (Pdr5, Pdr12, and Lem3) and also requires mature mannosylphosphosphingolipids.

In the presence of these components, *pdr10∆* cells significantly overincorporate Pdr12 into the DRM fraction. Pdr10 thus functions as a *negative regulator* of Pdr12 incorporation into DRMs. Slight increases in Pdr5 and Lem3 association with the DRM fraction are also seen, while Gas1 and Chs3 distributions are unchanged. Pdr12 has been estimated to be present at approximately 750 molecules per cell (Ghaemmaghami et al. [@CR36]), and approximately one-third of the total is shifted to the DRM fraction in *pdr10∆* membranes relative to wild-type membranes (Table [3](#Tab3){ref-type="table"}). Therefore, approximately 250 additional Pdr12 molecules per cell would become incorporated into the DRM fraction in the absence of Pdr10. In the same study, levels of Ste20 were estimated at approximately 260 molecules per cell, and both Dnf1 and Dnf2 exhibited lower but still detectable signals; however, Pdr10 could not be detected at all (Ghaemmaghami et al. [@CR36]). Therefore, Pdr10 levels must be substantially lower than 250 molecules per cell, which means that Pdr10 is substoichiometric with the Pdr12 population that is shifted to the DRM fraction in *pdr10∆* membranes. It thus seems unlikely that the overincorporation of Pdr12 in the DRM fraction of *pdr10∆* membranes reflects the loss of a stoichiometric association between Pdr10 and Pdr12.

One could also envision the redistribution of Pdr12 into the DRM fraction as arising from an endocytic defect, such that an intracellular pool of Pdr12 would effectively relocalize to the plasma membrane in the absence of Pdr10. The proposed link between endocytosis and exit from the DRM fraction (Lauwers and Andre [@CR64]; Lauwers et al. [@CR65]) would imply that such an intracellular pool would become available for partitioning into the DRM fraction upon such relocalization. In this model, the plasma membrane Pdr12 would be in equilibrium between a microenvironment that gives rise to a DRM fraction and a microenvironment that does not, while intracellular Pdr12 would instead be entirely associated with the detergent-soluble fraction. The absence of Pdr12 endocytosis in *pdr10∆* cells would then result in the total Pdr12 population equilibrating between these two microenvironments, rather than just a plasma membrane population doing so. Were this to be the case, the association of approximately 60% of total Pdr12 with the DRM fraction in *pdr10∆* cells would reflect the intrinsic affinity of Pdr12 for this fraction, while no intracellular Pdr12 would be found in the DRM fraction. The amount of Pdr12 in the DRM fraction would thus vary between 0% and 60%. The association of approximately 30% of total Pdr12 with the DRM fraction in wild-type cells would thus imply the presence of approximately 50% of total Pdr12 in an intracellular pool. However, we demonstrated that a functional Pdr12-GFP chimera is predominantly localized to the plasma membrane (Fig. [10](#Fig10){ref-type="fig"}b). Only ≤ 30% of cells exhibited any detectable intracellular Pdr12-GFP, and the vast majority of such cells also displayed plasma membrane Pdr12-GFP. Moreover, this localization pattern was equivalent in both wild-type and *pdr10∆* cells. Therefore, the intracellular population of Pdr12 is likely to be much less than 50% of the total, and there is no evidence that *pdr10∆* cells lack this population. These observations are inconsistent with the idea that Pdr12 accumulation in the DRM fraction of *pdr10∆* membranes arises from relocalization of Pdr12 to the plasma membrane. We favor, therefore, the idea that the composition of plasma membrane in cells lacking Pdr10 is itself different from that of the wild-type plasma membrane in a way that results in overincorporation of Pdr12 into the DRM fraction.

The gradient flotation assay we used to examine DRM incorporation does not provide information about the actual size of any detergent-resistant structures present in the yeast plasma membrane, but is only sensitive to density during fractionation. It is not rigorously established whether microdomains of native membranes can be stably maintained during the lysis, extraction, and flotation procedure, and it has been argued that detergent treatment can induce DRM formation in homogeneous model membranes (Lichtenberg et al. [@CR69]). However, it is hard to see how such an effect could be specifically enhanced by the absence of such a rare protein as Pdr10. Therefore, the higher occupancy of Pdr12 in the DRM fraction observed in *pdr10∆* membranes would represent either its increased partitioning into a specialized membrane subdomain or its increased interaction with boundary lipids that are resistant to removal by detergent. It thus seems that the microenvironment of Pdr12 in the native membrane is altered in the absence of Pdr10.

The most parsimonious model to accommodate all of the observations we have made is that the normal function of Pdr10 is to counteract some of the protein or lipid movements that are needed to establish a specific microdomain in the plasma membrane. Hence, when Pdr10 is absent, there is aberrant or excess formation of this microdomain, and Pdr12 becomes sequestered. Chs3 and Gas1 do not get trapped in this way. Pdr12 sequestered in such a compartment may be more resistant to the processes responsible for its endocytosis, explaining why it accumulates to a higher than normal level in *pdr10∆* cells. If Pdr12, Lem3, and Pdr5 are all required for formation of this microdomain, the observed epistasis among these membrane proteins would be explained, because removal of a required microdomain component would disrupt the microdomain and mimic the loss of a negative regulator. Similarly, if the proposed microdomain regulated by Pdr10 requires mature sphingolipids for its formation, then alteration of sphingolipid composition could also ameliorate the effects resulting from the absence of Pdr10, as we observed. Lem3 and Pdr5 are both present at higher levels than Pdr12 (Ghaemmaghami et al. [@CR36]), which provides a possible explanation for why their shift to the DRM fraction (Table [3](#Tab3){ref-type="table"}) is not statistically significant: if Pdr12 is also required for microdomain formation and is less abundant than Lem3 or Pdr5, it will be limiting for microdomain formation, such that the amount of Lem3 and Pdr5 shifted to the DRM fraction is smaller.

The precise nature of the putative sphingolipid-dependent microdomain on which Pdr10 has its effect is unclear. Pdr12, Dnf1, Dnf2, Lem3, and Pdr5 do not accumulate in the ER in *pdr10∆* cells, and we have shown that Pdr12 and Pdr5 are active in these cells. The absence of Pdr10 also does not activate the unfolded-protein response pathway (Ron and Walter [@CR89]) (data not shown), providing further evidence that these membrane proteins are not misfolded. Therefore, this microdomain should be viewed as an *accretion* of functional proteins rather than as an *aggregate* of unfolded proteins. It has been reported that association of permeases into \~300-nm patches in the membrane requires maintenance of the transmembrane electrochemical potential (Grossmann et al. [@CR40]). Also, it is now generally accepted that segregation of membrane proteins into the DRM fraction in yeast and other eukaryotes depends on the presence of both sterols and sphingolipids (Bagnat et al. [@CR6]; Dupré and Haguenauer-Tsapis [@CR27]; Hearn et al. [@CR44]). Formation of large oligomers of Pma1 is required for the segregation of this protein into the DRM fraction (Bagnat et al. [@CR7]; Lee et al. [@CR66]), and there is ample evidence for certain members of the ABC transporter family that their native state in the plasma membrane is as a large homomultimer (Poruchynsky and Ling [@CR85]; Xu et al. [@CR113]). Thus, both protein-protein and lipid-protein interactions can contribute in a *positive* sense to microdomain formation, and indeed our epistasis analysis provides indirect evidence for both. Pdr10 acts as a *negative* regulator of the establishment and/or maintenance of plasma membrane microdomains. This suggests that microdomain assembly and breakdown are quite dynamic processes in vivo.

If microdomains have a critically important role in the physiological functions of the plasma membrane, one might question why a *pdr10∆* mutant is viable. However, all of the evidence we have presented indicates that microdomain formation still occurs in cells lacking Pdr10 and that the defect is in the efficiency of microdomain disassembly. Moreover, there are yet other ABC transporters encoded in the *S. cerevisiae* genome whose function may be semiredundant with that of Pdr10 and, hence, partially mask the true effect of the problems that might be caused if microdomains remained too static. The latter consideration may explain why we observed some strain-background dependence in the phenotypes conferred by a *pdr10∆* mutation. In this regard, it is also interesting to note that the noncoding region of the *PDR10* gene has been identified as a mutational hotspot in the *S. cerevisiae* genome (Fay and Benavides [@CR33]). Thus, different lineages of this yeast may have adapted to cope with different demands for Pdr10 function. It is also important to note that the functional significance of the putative Pdr10-regulated microdomain is unclear; it is quite possible that this structure is actually a pathological association of functional Pdr12, Pdr5, and Lem3 in the presence of sphingolipids, and we do not propose to identify it with one of the previously defined compartments of the yeast plasma membrane.

The function of Pdr10 at the molecular level and the means by which its biochemical activity contravenes microdomain formation or maintenance have yet to be elucidated. Possibly, Pdr10 catalyzes outward translocation of an as yet unidentified lipid substrate, by analogy to its paralogous ABC transporter, Pdr5. Alternatively, the fact that Pdr10 itself localizes in discrete puncta in the plasma membrane may be important. For example, the microdomain compartment that appears to accumulate when Pdr10 is absent might be formed from (or beside) the subdomain normally occupied by Pdr10 itself. Hence, Pdr10 could help to occlude or exclude other integral membrane proteins from this same region without invoking any need for it to have transport activity. Another possibility is that, when Pdr10 is embedded in the plasma membrane, it dynamically associates with a specific set of lipids (or even other proteins); in this way, Pdr10 may act as a "detergent" to "solubilize" these components and thus enhance their dispersal within the plane of the membrane.
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